Molecular and Clinical Oncology
Overview
Molecular and Clinical Oncology is a scientific journal, published since 2012 in English. The journal's country of origin is United Kingdom and its primary focus area is oncology.
Details
Details
Abbr.
Mol Clin Oncol
Start
2012
End
Continuing
Frequency
Bimonthly
p-ISSN
2049-9450
e-ISSN
2049-9469
Country
United Kingdom
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 12586
19
SJR / Ranks: 9694
446
CiteScore / Ranks: 9425
2.60
Recent Articles
1.
Koloutsou M, Soura M, Andreikos D, Spandidos D, Yavropoulou M, Georgakopoulou V
Mol Clin Oncol
. 2025 Mar;
22(4):36.
PMID: 40083863
Endocrine paraneoplastic syndromes (PNS) are uncommon but clinically impactful manifestations associated with malignancies, particularly lung cancer, most notably small-cell lung cancer. These syndromes arise from ectopic hormone production by malignant...
2.
Alshajrawi O, Tengku Din T, Marzuki S, Maulidiani M, Mohd Rusli N, Badrol Hisham N, et al.
Mol Clin Oncol
. 2025 Mar;
22(4):35.
PMID: 40083862
An overview of metabolomics in cancer research, focusing on the identification of biomarkers, pharmacological targets and therapeutic agents, is provided in the present review. The fundamentals of metabolomics, the role...
3.
Miao C, Sun R, Ji D, Wu M, Fu Q, Mei L, et al.
Mol Clin Oncol
. 2025 Mar;
22(4):37.
PMID: 40083861
Lung cancer is one of the most common and lethal malignant tumors. Currently, surgical resection is the most effective treatment for early-stage lung cancer, and often results in favorable recovery...
4.
Adan M, Hu B, Yan M, Hidig S, Dai Y, Li G
Mol Clin Oncol
. 2025 Feb;
22(4):34.
PMID: 40012901
According to increasing evidence, high-density lipoproteins (HDLs) may raise prostate-specific antigen (PSA) levels in the prostate. The link between HDL-cholesterol (C) and PSA, on the other hand, is debatable and...
5.
Hashimoto K, Nishimura S, Goto K
Mol Clin Oncol
. 2025 Feb;
22(4):31.
PMID: 39989606
Anti-programmed cell death 1 (PD-1)/PD-1 ligand-1 (PD-L1) drugs have been used clinically, including those for skin cancer, with reasonable efficacy. Despite extensive ongoing research on bone and soft tissue sarcomas,...
6.
El Ahanidi H, El Azzouzi M, Addoum B, Tetou M, Hassan I, Al Bouzidi A, et al.
Mol Clin Oncol
. 2025 Feb;
22(4):33.
PMID: 39989605
Signal transducer and activator of transcription (STAT) proteins are cytoplasmic transcription factors known to play key roles in numerous physiological and pathological processes, from pathogen response to cancer modulation. However,...
7.
Irianiwati I, Gurky T, Anwar S, Bawono R, Dwianingsih E
Mol Clin Oncol
. 2025 Feb;
22(4):32.
PMID: 39989604
Triple-negative breast cancer (TNBC) is highly aggressive and has a poor prognosis. TNBC is commonly reported in young women and often relapses quickly, exhibiting aggressive characteristics. It is also linked...
8.
Zeng J, Gao R, Yang K, Li J, Tan F, Li P, et al.
Mol Clin Oncol
. 2025 Feb;
22(3):29.
PMID: 39926371
Dedifferentiated liposarcoma (DDLPS) is a subtype of LPS characterized by two distinct levels of differentiation and morphological structures, comprising areas of well-differentiated LPS and dedifferentiated, non-lipogenic, highly malignant components. DDLPS...
9.
Lv W, Gao J, Guo X
Mol Clin Oncol
. 2025 Feb;
22(3):30.
PMID: 39926370
Embryonal tumors with multilayered rosettes (ETMR) are relatively rare but highly aggressive intracranial tumors that mainly occur in children under four years of age. Despite high-intensity and multi-modal treatment, the...
10.
Mahawongkajit P, Chimparlee B
Mol Clin Oncol
. 2025 Feb;
22(3):28.
PMID: 39926369
Enteral nutrition is the preferred method for providing nutrition to patients who can consume food orally or via a feeding tube. In the case of patients with advanced esophageal cancer,...